# EDGAR Filing Document

**Accession Number:** 0001513525
**File Stem:** 0001213900-23-023830
**Filing Date:** 2023-3
**Character Count:** 3464
**Document Hash:** e8b2949f5ca8d383dddf0097049b33a8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-023830.hdr.sgml**: 20230329

**ACCESSION NUMBER**: 0001213900-23-023830

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230329

**DATE AS OF CHANGE**: 20230329

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ADIAL PHARMACEUTICALS, INC.
- **CENTRAL INDEX KEY:** 0001513525
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 800667150
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38323
- **FILM NUMBER:** 23771605

**BUSINESS ADDRESS:**
- **STREET 1:** 1180 SEMINOLE TRAIL
- **STREET 2:** SUITE 495
- **CITY:** CHARLOTTESVILLE
- **STATE:** VA
- **ZIP:** 22901
- **BUSINESS PHONE:** 434-422-9800

**MAIL ADDRESS:**
- **STREET 1:** 1180 SEMINOLE TRAIL
- **STREET 2:** SUITE 495
- **CITY:** CHARLOTTESVILLE
- **STATE:** VA
- **ZIP:** 22901

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADial Pharmaceuticals, L.L.C.
- **DATE OF NAME CHANGE:** 20170515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Adial Pharmaceuticals, L.L.C.
- **DATE OF NAME CHANGE:** 20110218

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 14A**

**Proxy Statement Pursuant to Section 14(a) of the Securities**

**Exchange Act of 1934 (Amendment No.)**

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ **Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))**

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material Pursuant to §240.14a-12

**ADIAL PHARMACEUTICALS, INC.**

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒ No
 fee required

☐ Fee paid previously with preliminary materials

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

**PLEASE VOTE YOUR PROXY TODAY!**

March 29, 2023

Dear Stockholder,

According to our latest records, we have not received your voting instructions for the Special Meeting of the stockholders of Adial Pharmaceuticals, Inc. to be held on April 12, 2023, at 10:00 a.m. Eastern Time.

**Your vote is critically important, no matter how many shares you hold. Please take one moment of your time today to vote your shares.** 

**<u>The Board recommends a vote FOR the Reverse Stock Split Proposal (Proposal 1) and FOR the Adjournment Proposal (Proposal 2). After careful consideration, the Board has determined that each proposal is in the best interests of the Company and its stockholders and has approved each proposal.</u>**

**Please vote today without further delay**. Voting by telephone or internet by following the instructions on the voting card sent to you will assist in recording your vote promptly. See instructions below. If you need assistance voting your shares, please call D.F. King & Co., Inc. toll free at (800) 967-0261. On behalf of your Board of Directors, thank you for your cooperation and continued support.

---

| |
|:---|
| Sincerely, |
| /s/ Cary J. Claiborne |
| Cary J. Claiborne |
| *President and Chief Executive Officer* |

---

T<u>hree **easy ways to vote**</u>

![](image_001.jpg)